Article
TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Human immunology - 1 Dec 2020
Arndt Mary F, Koohestani Darush M, Chobrutskiy Boris I, Mihyu Moody M, Diaz Michael, Gozlan Etienne C, Yeagley Michelle, Zaman Saif, Roca Andrea M, Blanck George
Abstract excerpt
Common or dominant, T-cell receptor (TCR), V and J usage, in combination with particular human leukocyte antigen (HLA) alleles, has been associated with differing outcomes in viral infections, autoimmunity, and more recently, in cancer. Cervical cancer in particular represents the most dramatic series of distinctions of outcomes associated with differing combinations of dominant V or J usage and HLA alleles,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
